03/11/2026
Ozempic and Mounjaro have transformed conversations around diabetes and weight management. But could their potential extend to type 1 diabetes?
That question is at the heart of PhD research by Amanda Purcell from the Kolling Institute.
On the latest Tomorrow’s Medicine Today, Amanda sits down with James Elliott and Matt Doan to unpack her research, challenge some common misconceptions about type 1 diabetes and explore what it takes to turn scientific discovery into a clinical trial.
It’s a fascinating conversation about curiosity, collaboration and where diabetes research could take us next.
Listen to the full episode –
🎧 On Spotify: https://bit.ly/3UZc9uF
🎧 On our website: https://bit.ly/4sDLK1M